STAT | Reporting from the frontiers of health and medicine 中文 关注 STAT+：Pharmalittle：我们读到关于葛兰素史克（GSK）与中国一款药物的交易、美国裁员以及更多内容” GSK 持续推进其管线扩充，获得了在中国开发的多发性骨髓瘤治疗药物的全球权益。 STAT+: Pharmalittle: We’re reading about a GSK deal for a drug from China, job losses in the U.S., and more statnews.com STAT | Reporting from the frontiers of health and medicine 中文 RSS thenote.app
